Carrie B. Lee

University of North Carolina at Chapel Hill

Also affiliated with UNC Lineberger Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial”.

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00658-6

N/A

4.8DataRank · unranked

234 citations

Anita Giobbie‐Hurder, Srinika Ranasinghe, Katrina Kao, Ana Lako, Junko Tsuji +32 more

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

UNC Libraries(2021)10.17615/d9z4-0943

N/A

0.881DataRank · unranked

26 citations

Chun-Xiao Xu, Michael D. Cameron, D. Neil Hayes, Lucian R. Chirieac, Jing Ouyang +38 more

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Clinical Cancer Research(2010)10.1158/1078-0432.ccr-10-0199

N/A

0.853DataRank · unranked

294 citations

Xiaoying Yin, Katherine A. Hoadley, Yufeng Liu, Michele C. Hayward, Christopher R. Cabanski +15 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0.520DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

Feasibility, Acceptability, and Utility of Remote Patient-Reported Outcomes Monitoring in Patients With Lung Cancer: A Moovcare© Study

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.07.016

N/A

0.165DataRank · unranked

2 citations

Allison M. Deal, Chaely J Medley, Ashley A. Weiner, Lara Novak, Amanda Gentry +10 more

The Vanguard study: An NCI cancer screening research network multi-cancer detection feasibility study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e22522

N/A

0.165DataRank · unranked

2 citations

Katherine A. Guthrie, Yikyung Park, Quyen Ngo‐Metzger, Rebecca Kaltman, Carrie B. Lee +4 more

Coronary Artery Calcifications and Cardiac Risk After Radiation Therapy for Stage III Lung Cancer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.08.017

N/A

0DataRank · unranked

35 citations

Hayley Malkin, Nicholas D. Patchett, Kevin A. Pearlstein, Hillary Heiling, Sean McCabe +11 more

Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100037

N/A

0DataRank · unranked

15 citations

Wenjuan Zhu, George C. Gabriel, Cullen B. Young, Kylia Williams, Lisa J. Martin +36 more

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

UNC Libraries(2020)10.17615/5tdz-sn55

N/A

0DataRank · unranked

0 citations

Philip S. Bernard, Alden M. Parsons, Kenneth L. Muldrew, Leigh B. Thorne, Mark A. Socinski +13 more